Arcutis Biotherapeutics, Inc. Quarterly Interest Expense in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Arcutis Biotherapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2021 to Q1 2024.
  • Arcutis Biotherapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $7.48M, a 6.22% increase year-over-year.
  • Arcutis Biotherapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $30.2M, a 44.6% increase year-over-year.
  • Arcutis Biotherapeutics, Inc. annual Interest Expense for 2023 was $29.7M, a 89.8% increase from 2022.
  • Arcutis Biotherapeutics, Inc. annual Interest Expense for 2022 was $15.7M.
  • Arcutis Biotherapeutics, Inc. annual Interest Expense for 2021 was $0.000.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $30.2M $7.48M +$438K +6.22% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $29.7M $7.76M +$847K +12.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $28.9M $7.56M +$2.66M +54.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $26.2M $7.35M +$5.35M +267% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $20.9M $7.04M +$5.2M +283% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $15.7M $6.92M +$6.92M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $8.74M $4.9M +$4.9M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $3.84M $2M +$2M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $1.84M $1.84M +$1.84M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.